Breast cancer remains a major global health challenge, with treatment strategies varying widely across regions.
In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited (“CMS” or the “Group”) has been included in ...
China’s State Administration for Market Regulation (“SAMR”) put into effect its Compliance Guidelines for Healthcare Companies ...
Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...
StairMed, a Shanghai-based medical technology company, announced on Monday that it has raised 350 million yuan ($48 million) ...
China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...
"We are honored to be named Industry Co-Chair of the National TBI Registry Coalition," said Mark White, CEO of Nexalin. "This role reflects our dedication to improving the lives of those affected by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback